What is Datos?
Datos Health offers an AI-driven remote patient monitoring platform designed to automate hybrid care, enhance patient outcomes, and alleviate clinician workload. Their services include customizable care pathways across various clinical domains such as cardiac rehabilitation, oncology care, and diabetes management. The OpenCare platform allows healthcare teams to build and optimize programs tailored to their patients' needs, promoting patient engagement and self-management. With a focus on flexibility and automation, Datos Health aims to transform traditional remote monitoring into a comprehensive remote care experience.
How much funding has Datos raised?
Datos has raised a total of $7M across 1 funding round:
Series A
$7M
Series A (2020): $7M with participation from Vertex, Industry Ventures, Angular Ventures, and Crescendo Venture Partners
Key Investors in Datos
Vertex
Vertex is a venture capital firm that likely focuses on investing in innovative technology and healthcare companies.
Industry Ventures
Industry Ventures is a private equity and venture capital firm that specializes in providing flexible capital solutions across the full lifecycle of venture investing. The firm partners with entrepreneurs, startups, and growth-stage companies to support their development from early-stage ventures through later-stage growth and buyout transitions. Leveraging a comprehensive platform, complementary investment funds, and an extensive network of industry contacts, Industry Ventures delivers strategic guidance, capital, and operational support to help portfolio companies achieve long-term success.
Angular Ventures
Angular Ventures is likely a venture capital firm that provides funding and strategic support to early-stage technology companies.
What's next for Datos?
The recent major strategic investment positions Datos Health for significant scaling and further development of its AI-driven remote patient monitoring solutions. This capital infusion is expected to accelerate the expansion of its OpenCare platform, enabling more healthcare providers to adopt automated hybrid care models. The company's focus on customizable care pathways for conditions like cardiac rehabilitation, oncology, and diabetes suggests a strategic push into specialized healthcare markets. Future growth will likely involve enhancing AI capabilities for predictive analytics and deepening clinician workflow integration, solidifying Datos Health's role in the evolving landscape of remote patient care.
See full Datos company page
